Skip to content
Trial Eligibility
Menu

Differing Levels of Hypoglycemia

NCT02445781

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Hypoglycemia can produce a spectrum of pro-inflammatory and pro-atherothrombotic changes. To date no studies appear to have investigated the effects of differing levels of hypoglycemia on the vasculature and pro-atherothrombotic balance during hypoglycemia in healthy man. The specific aim of our study will be to determine the effects of differing levels of hypoglycemia on in-vivo vascular biologic mechanisms in a healthy population.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Hypoglycemia

Eligibility basics and study details

Study type
Interventional
Phase
Early Phase 1
Ages
18 to 55 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Maryland, Baltimore
Last updated on ClinicalTrials.gov
November 10, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 2

  • University of Maryland, Baltimore · Baltimore, MD
  • University of Maryland, Baltimore · Baltimore, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.